These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Geishofer G, Binder A, Müller M, Zöhrer B, Resch B, Müller W, Faber J, Finn A, Endler G, Mannhalter C, Zenz W, Central European Meningococcal Genetic Study Group. Eur J Pediatr; 2005 Aug; 164(8):486-90. PubMed ID: 15843979 [Abstract] [Full Text] [Related]
4. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Haralambous E, Hibberd ML, Hermans PW, Ninis N, Nadel S, Levin M. Crit Care Med; 2003 Dec; 31(12):2788-93. PubMed ID: 14668616 [Abstract] [Full Text] [Related]
15. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults. Ringelstein M, Jung A, Berger K, Stoll M, Madlener K, Klötzsch C, Schlachetzki F, Stolz E. J Neurol; 2012 Nov; 259(11):2287-92. PubMed ID: 22527222 [Abstract] [Full Text] [Related]
18. Contribution of the type 1 plasminogen activator inhibitor 4G/5G gene polymorphism to impaired fibrinolysis in vital exhaustion. von Känel R, Maly FE, Frey K, Fischer JE. Ital Heart J; 2003 Nov; 4(11):791-6. PubMed ID: 14699709 [Abstract] [Full Text] [Related]
19. Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients. Menges T, Hermans PW, Little SG, Langefeld T, Böning O, Engel J, Sluijter M, de Groot R, Hempelmann G. Lancet; 2001 Apr 07; 357(9262):1096-7. PubMed ID: 11297964 [Abstract] [Full Text] [Related]